Tap to start →
Photo: National Cancer Institute / Unsplash
1 / 3
Exenatide was the first GLP-1 receptor agonist approved in the US, a twice-daily injection for type 2 diabetes first sold as Byetta in 2005.
2 / 3
Exenatide is a lab-made version of exendin-4, a hormone first found in the saliva of the Gila monster lizard.
3 / 3
Exenatide explains where today's GLP-1 medicines came from and why longer half-lives changed dosing from twice a day to once a week.
Exenatide was the first GLP-1 receptor agonist approved in the US, a twice-daily injection for type 2 diabetes first sold as Byetta in 2005.
Tap below for the full page. Not medical advice; talk to your clinician about your care.